The role of 'colonization pressure' in the spread of vancomycin- resistant enterococci: An important infection control variable

Archives of Internal Medicine

Volumn 158, Issue 10, 1998, Pages 1127-1132

  Bonten, Marc J M ^a,b   Slaughter, Sarah ^b,c   Ambergen, Anton W ^a   Hayden, Mary K ^c   Van Voorhis, Jean ^b   Nathan, Catherine ^b   Weinstein, Robert A ^b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MA   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; DISEASE TRANSMISSION; ENTERIC FEEDING; ENTEROCOCCUS; FEMALE; HAND WASHING; HOSPITAL INFECTION; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; APACHE; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTERAL NUTRITION; ENTEROCOCCUS; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; VANCOMYCIN;

EID: 0032565588     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.10.1127     Document Type: Article

References (23)

1. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med. 1992;327:88-93.
2. Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol. 1990;11:589-594.
3. Albert RK, Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med. 1981;304:1465-1466.
4. Balow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis. 1992;15(suppl):37S-42S.
5. McGowan JE. Do intensive hospital control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 1994;15:478-483.
6. Bonten MJM, Gaillard CA, Johanson WG Jr, et al. Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med. 1994;150:1332-1340.
7. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996;125: 448-456.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Villanova, Pa: NCCLS; 1993. Approved standard M7-A3.
9. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Villanova, Pa: NCCLS; 1993. Approved standard M2-A3.
10. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
11. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994;38:1363-1367.
12. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20:1126-1133.
13. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42:597-599.
14. Bonten M, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348: 1615-1619.
15. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis. 1995;171:614-624.
16. Bergmans DCJJ, Bonten MJM, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother. 1997; 39:527-535.
17. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274:639-644.
18. Quale J, Landman D, Saurina G, Atwood E, Ditore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 1996;23:1020-1025.
19. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol. 1996;17:36-41.
20. Hariharan R, Nathan C, McMahon C, Tyrrell J. Kabins S, Weinstein RA. Epidemiology of vancomycin-resistant enterococci in ICU patients [abstract]. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, La: American Society for Microbiology; 1993; 849:275.
21. Rhinehart E, Smith NE, Wennerstein C, et al. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990;323: 1814-1818.
22. Souba WW. Nutritional support. N Engl J Med. 1997;336:41-48.
23. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.